Dabrafenib and trametinib vs anti-PD(L)1 for the adjuvant treatment of locally advanced BRAF-mutant melanoma: A systematic review and meta-analysis.

Authors: Daniel Vilarim Araujo, Bruno Lins de Souza, Mariana Fauth Seibel, Aline Fusco Fares, Vitor Teixeira Liutti

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.e21566

Source: Full article

---

Abstract

e21566